Impact Therap-b (7630.HK) Stock Competitors & Peer Comparison
See (7630.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 7630.HK | HK$12.74 | -3.70% | 3.5B | -10.27 | -HK$1.24 | N/A |
| 1093.HK | HK$8.41 | -1.06% | 95.9B | 22.56 | HK$0.37 | +3.45% |
| 2186.HK | HK$2.18 | +1.40% | 8.7B | 12.10 | HK$0.18 | N/A |
| 1666.HK | HK$3.52 | -1.12% | 4.5B | 9.60 | HK$0.37 | +5.88% |
| 2630.HK | HK$66.60 | +27.83% | 4.4B | -24.67 | -HK$2.70 | N/A |
| 2410.HK | HK$8.42 | +10.79% | 3.2B | -25.61 | -HK$0.33 | N/A |
| 6086.HK | HK$0.83 | -1.19% | 1.1B | -1482.14 | -HK$0.00 | N/A |
| 2563.HK | HK$3.55 | -3.79% | 769.4M | -8.66 | -HK$0.41 | N/A |
| 1643.HK | HK$0.82 | +1.23% | 590.4M | -41.00 | -HK$0.02 | N/A |
Stock Comparison
7630.HK vs 1093.HK Comparison July 2026
7630.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7630.HK stands at 3.5B. In comparison, 1093.HK has a market cap of 95.9B. Regarding current trading prices, 7630.HK is priced at HK$12.74, while 1093.HK trades at HK$8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7630.HK currently has a P/E ratio of -10.27, whereas 1093.HK's P/E ratio is 22.56. In terms of profitability, 7630.HK's ROE is +0.33%, compared to 1093.HK's ROE of +0.11%. Regarding short-term risk, 7630.HK is more volatile compared to 1093.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 7630.HK.Check 1093.HK's competition here